Pyruvic Acid

9 trials 8 recruiting

Filter these 9 trials by condition, phase, country and more.

Open in Search →

9 Registered trials

8 Recruiting

1 Completed trials

3 Sponsors

1 Countries

Phase II

Phase I/II

Phase II: 8 Phase I/II: 1

Indications tested

Neuroendocrine carcinoma 1 Neuroendocrine carcinoma metastatic 1

Sponsors using this IMP

Aarhus Universitet 7 Region Midtjylland 1 Rigshospitalet 1

All trials

9 total

MR-HYPERPOLARISATION SCANNING WITH HYPERPOLARISED PYRUVATE (13C) IN PANCREATIC CANCER PATIENTS – A FEASIBILITY STUDY Recruiting

2024-517358-86-00 Phase II 1 country Aarhus Universitet
Chronic kidney disease – imaging the metabolic derangements with ultra-sensitive MRI Recruiting

2024-512491-35-00 Phase II 1 country Aarhus Universitet
IMPROCAS - Improved Prediction of Ovarian Cancer Surgery Recruiting

2023-503398-39-00 Phase II 1 country Aarhus University
Early detection of hepatocellular carcinoma by Hyperpolarized [1- 13C]pyruvate MRI Recruiting

2024-512490-27-00 Phase II 1 country Aarhus Universitet
Phase IIa Clinical Trial: Feasibility Study on Non-Invasive Simultaneous Hyperpolarized [1-13C]Pyruvate Magnetic Resonance Spectroscopy and … Recruiting

2024-516131-28-00 Phase II 1 country Rigshospitalet
MRI of Neurometabolic Impairment in ALS and TIA Using Hyperpolarized Pyruvate Recruiting

2024-516954-24-00 Phase II 1 country Aarhus Universitet
MRI with hyperpolarized pyruvate in gliblastoma - a phase II study Recruiting

2024-515408-37-00 Phase II 1 country Aarhus Universitet
Investigation of cardiac metabolism in patients with heart failure using hyperpolarized MRI Recruiting

2024-515414-40-00 Phase I/II 1 country Region Midtjylland
HOPE in Diabetic Kidney Disease (HyperpOlarised PyruvatE in Diabetic Kidney Disease) Ended

2023-508824-36-00 Phase II 1 country Aarhus Universitet

Showing 1–9 of 9 trials

← All drugs A–Z